{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:41:26Z","timestamp":1792683686147,"version":"4.5.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.molmed.2024.01.007","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:04:35Z","timestamp":1708905875000},"page":"278-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients"],"prefix":"10.1016","volume":"30","author":[{"given":"Chiara","family":"Mozzetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Sartorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4964-0095","authenticated-orcid":false,"given":"Pier Lorenzo","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2024.01.007_bb0005","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.51.5.786","article-title":"Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis","volume":"51","author":"Allfrey","year":"1964","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.01.007_bb0010","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0092-8674(00)81063-6","article-title":"Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation","volume":"84","author":"Brownell","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0015","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0092-8674(00)81821-8","article-title":"The TAFII250 subunit of TFIID has histone acetyltransferase activity","volume":"87","author":"Mizzen","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0020","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/384641a0","article-title":"The CBP co-activator is a histone acetyltransferase","volume":"384","author":"Bannister","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.01.007_bb0025","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0092-8674(00)82001-2","article-title":"The transcriptional coactivators p300 and CBP are histone acetyltransferases","volume":"87","author":"Ogryzko","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.272.5260.408","article-title":"A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p","volume":"272","author":"Taunton","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.molmed.2024.01.007_bb0035","doi-asserted-by":"crossref","first-page":"14503","DOI":"10.1073\/pnas.93.25.14503","article-title":"HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes","volume":"93","author":"Rundlett","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.01.007_bb0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/bies.950170510","article-title":"Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function","volume":"17","author":"Yoshida","year":"1995","journal-title":"BioEssays"},{"key":"10.1016\/j.molmed.2024.01.007_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0959-437X(03)00048-0","article-title":"Muscular dystrophies: genes to pathogenesis","volume":"13","author":"Dalkilic","year":"2003","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.molmed.2024.01.007_bb0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","article-title":"Modulation of cellular processes by histone and non-histone protein acetylation","volume":"23","author":"Shvedunova","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0055","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.molmed.2024.01.007_bb0060","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cell.2018.04.033","article-title":"Time-resolved analysis reveals rapid dynamics and broad scope of the CBP\/p300 acetylome","volume":"174","author":"Weinert","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41576-018-0072-4","article-title":"The many lives of KATs \u2014 detectors, integrators and modulators of the cellular environment","volume":"20","author":"Sheikh","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2024.01.007_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf2687","article-title":"CBP and Gcn5 drive zygotic genome activation independently of their catalytic activity","volume":"9","author":"Ciabrelli","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molmed.2024.01.007_bb0075","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41588-022-01091-2","article-title":"Histone editing elucidates the functional roles of H3K27 methylation and acetylation in mammals","volume":"54","author":"Sankar","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2024.01.007_bb0080","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrm2346","article-title":"The Rpd3\/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men","volume":"9","author":"Yang","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Rev. Genet."},{"key":"10.1016\/j.molmed.2024.01.007_bb0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00018-020-03599-4","article-title":"Regulation of histone deacetylase activities and functions by phosphorylation and its physiological relevance","volume":"78","author":"Bahl","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.molmed.2024.01.007_bb0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cell.2005.10.023","article-title":"Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription","volume":"123","author":"Carrozza","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0100","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.molcel.2005.11.021","article-title":"Eaf3 chromodomain interaction with methylated H3-K36 links histone deacetylation to Pol II elongation","volume":"20","author":"Joshi","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0105","doi-asserted-by":"crossref","first-page":"19183","DOI":"10.1073\/pnas.0805514105","article-title":"HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment","volume":"105","author":"Colussi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.01.007_bb0110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature07238","article-title":"S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons","volume":"455","author":"Nott","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.01.007_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yjmcc.2021.08.007","article-title":"Post-translational modifications talk and crosstalk to class IIa histone deacetylases","volume":"162","author":"Guttzeit","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/35040593","article-title":"Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation","volume":"408","author":"McKinsey","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.01.007_bb0125","doi-asserted-by":"crossref","first-page":"17335","DOI":"10.1073\/pnas.0706487104","article-title":"Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases","volume":"104","author":"Lahm","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.01.007_bb0130","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nchembio.2140","article-title":"Structural insights into HDAC6 tubulin deacetylation and its selective inhibition","volume":"12","author":"Miyake","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0135","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15368","article-title":"Histone deacetylase 10 structure and molecular function as a polyamine deacetylase","volume":"8","author":"Hai","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.01.007_bb0145","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.chembiol.2020.07.002","article-title":"The chemical biology of reversible lysine post-translational modifications","volume":"27","author":"Wang","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0150","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018762","article-title":"Writers and readers of histone acetylation: structure, mechanism, and inhibition","volume":"6","author":"Marmorstein","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0155","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.molmed.2024.01.007_bb0160","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2024.01.007_bb0165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2013.09.011","article-title":"Mapping human epigenomes","volume":"155","author":"Rivera","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0170","doi-asserted-by":"crossref","first-page":"D512","DOI":"10.1093\/nar\/gku1267","article-title":"PhosphoSitePlus, 2014: mutations, PTMs and recalibrations","author":"Hornbeck","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2024.01.007_bb0175","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrm3841","article-title":"The growing landscape of lysine acetylation links metabolism and cell signalling","volume":"15","author":"Choudhary","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0180","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/15548627.2022.2062112","article-title":"Acetylation in the regulation of autophagy","volume":"19","author":"Xu","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.molmed.2024.01.007_bb0185","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","article-title":"Functions and mechanisms of non-histone protein acetylation","volume":"20","author":"Narita","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-cellbio-100616-060531","article-title":"The three-dimensional organization of mammalian genomes","volume":"33","author":"Yu","year":"2017","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0195","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41580-019-0132-4","article-title":"The role of 3D genome organization in development and cell differentiation","volume":"20","author":"Zheng","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0200","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.celrep.2019.09.023","article-title":"HDAC4 controls muscle homeostasis through deacetylation of myosin heavy chain, PGC-1\u03b1, and Hsc70","volume":"29","author":"Luo","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2024.01.007_bb0205","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0960-894X(97)00284-9","article-title":"Analogues of Trichostatin A and Trapoxin B as histone deacetylase inhibitors","volume":"7","author":"Jung","year":"1997","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.molmed.2024.01.007_bb0210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0215","article-title":"Hidden pharmacological activities of valproic acid: a new insight","volume":"142","author":"Singh","year":"2021","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.molmed.2024.01.007_bb0220","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1089\/ars.2011.4480","article-title":"Influence of natural and synthetic histone deacetylase inhibitors on chromatin","volume":"17","author":"Licciardi","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.molmed.2024.01.007_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201500902","article-title":"Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer","volume":"61","author":"Bultman","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.molmed.2024.01.007_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115746","article-title":"The application of PROTAC in HDAC","volume":"260","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.molmed.2024.01.007_bb0235","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z","article-title":"Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications","volume":"185","author":"Puri","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0240","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.molcel.2018.04.025","article-title":"Shaping gene expression by landscaping chromatin architecture: lessons from a master","volume":"71","author":"Sartorelli","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0245","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1101\/gad.10.19.2478","article-title":"Interaction and functional collaboration of p300\/CBP and bHLH proteins in muscle and B-cell differentiation","volume":"10","author":"Eckner","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2024.01.007_bb0250","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.1074\/jbc.271.15.9009","article-title":"Human p300 protein is a coactivator for the transcription factor MyoD","volume":"271","author":"Yuan","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.01.007_bb0255","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1128\/MCB.17.2.1010","article-title":"Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C","volume":"17","author":"Sartorelli","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1097-2765(00)80005-2","article-title":"Differential roles of p300 and PCAF acetyltransferases in muscle differentiation","volume":"1","author":"Puri","year":"1997","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0265","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/emboj\/16.2.369","article-title":"p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription","volume":"16","author":"Puri","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2024.01.007_bb0270","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1097-2765(00)80383-4","article-title":"Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program","volume":"4","author":"Sartorelli","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0275","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1097-2765(01)00373-2","article-title":"Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis","volume":"8","author":"Puri","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0280","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/emboj\/20.7.1739","article-title":"A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program","volume":"20","author":"Mal","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2024.01.007_bb0285","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.3390\/ijms24054306","article-title":"Histone deacetylases: molecular mechanism and therapeutic implications for muscular dystrophies","volume":"24","author":"Sandon\u00e0","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2024.01.007_bb0290","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2010.07.008","article-title":"MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin\/nNOS pathway","volume":"12","author":"Cacchiarelli","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2024.01.007_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105750","article-title":"Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy","volume":"170","author":"Spreafico","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.molmed.2024.01.007_bb0300","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1073\/pnas.1121159109","article-title":"Histone deacetylases 1 and 2 regulate autophagy flux and skeletal muscle homeostasis in mice","volume":"109","author":"Moresi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.01.007_bb0305","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1128\/MCB.00882-06","article-title":"Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2","volume":"27","author":"Gr\u00e9goire","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0310","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jmcb\/mjy066","article-title":"The HDAC3 enzymatic activity regulates skeletal muscle fuel metabolism","volume":"11","author":"Song","year":"2019","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0315","doi-asserted-by":"crossref","first-page":"E2865","DOI":"10.1073\/pnas.1121131109","article-title":"Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages","volume":"109","author":"Chen","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.01.007_bb0320","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nm.4245","article-title":"Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion","volume":"23","author":"Hong","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.01.007_bb0325","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.1073\/pnas.131198498","article-title":"The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis","volume":"98","author":"Zhang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.01.007_bb0330","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1172\/JCI31960","article-title":"Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers","volume":"117","author":"Potthoff","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2024.01.007_bb0335","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","article-title":"Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy","volume":"110","author":"Zhang","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0340","doi-asserted-by":"crossref","first-page":"17007","DOI":"10.1074\/jbc.M101508200","article-title":"A dynamic role for HDAC7 in MEF2-mediated muscle differentiation","volume":"276","author":"Dressel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.01.007_bb0345","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2010.09.004","article-title":"Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases","volume":"143","author":"Moresi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0350","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/jcsm.12891","article-title":"Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy","volume":"13","author":"Renzini","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.molmed.2024.01.007_bb0355","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3389\/fphys.2018.01387","article-title":"HDAC4 regulates skeletal muscle regeneration via soluble factors","volume":"9","author":"Renzini","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0360","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.15252\/embr.201439195","article-title":"HDAC4 promotes Pax7-dependent satellite cell activation and muscle regeneration","volume":"15","author":"Choi","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molmed.2024.01.007_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101062","article-title":"Histone deacetylase 5 regulates interleukin 6 secretion and insulin action in skeletal muscle","volume":"42","author":"Klymenko","year":"2020","journal-title":"Mol. Metab."},{"key":"10.1016\/j.molmed.2024.01.007_bb0370","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/JME-12-0095","article-title":"Histone deacetylase 5 regulates glucose uptake and insulin action in muscle cells","volume":"49","author":"Raichur","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0375","doi-asserted-by":"crossref","first-page":"8640","DOI":"10.1074\/jbc.RA118.007006","article-title":"HDAC5 catalytic activity suppresses cardiomyocyte oxidative stress and NRF2 target gene expression","volume":"294","author":"Hu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.01.007_bb0380","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1038\/s41467-022-34831-3","article-title":"Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-\u03b2 via Smad3 acetylation","volume":"13","author":"Osseni","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.01.007_bb0385","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/febs.15468","article-title":"Loss of HDAC11 accelerates skeletal muscle regeneration in mice","volume":"288","author":"N\u00fa\u00f1ez-\u00c1lvarez","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.molmed.2024.01.007_bb0390","first-page":"5123","article-title":"Sodium butyrate inhibits myogenesis by interfering with the transcriptional activation function of MyoD and myogenin","volume":"12","author":"Johnston","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0395","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.1073\/pnas.112218599","article-title":"Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases","volume":"99","author":"Iezzi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.01.007_bb0400","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1534-5807(04)00107-8","article-title":"Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin","volume":"6","author":"Iezzi","year":"2004","journal-title":"Dev. Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0405","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/embor.2009.88","article-title":"Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes","volume":"10","author":"Nebbioso","year":"2009","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molmed.2024.01.007_bb0410","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.cellbio.20.012103.135836","article-title":"Regulation of muscle mass by myostatin","volume":"20","author":"Lee","year":"2004","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0415","first-page":"832","article-title":"Loss of myostatin attenuates severity of muscular dystrophy in mdx mice","volume":"52","author":"Wagner","year":"2002","journal-title":"Neurol"},{"key":"10.1016\/j.molmed.2024.01.007_bb0420","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature01154","article-title":"Functional improvement of dystrophic muscle by myostatin blockade","volume":"420","author":"Bogdanovich","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.01.007_bb0425","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1038\/s41467-018-06068-6","article-title":"Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophy","volume":"9","author":"Malecova","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.01.007_bb0430","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2221249120","article-title":"A cellular and molecular spatial atlas of dystrophic muscle","volume":"120","author":"Stec","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.01.007_bb0435","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41420-023-01503-0","article-title":"Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD","volume":"9","author":"M\u00e1zala","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.molmed.2024.01.007_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105415","article-title":"Single cell sequencing maps skeletal muscle cellular diversity as disease severity increases in dystrophic mouse models","volume":"25","author":"Saleh","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.molmed.2024.01.007_bb0445","article-title":"Diverse effector and regulatory functions of fibro\/adipogenic progenitors during skeletal muscle fibrosis in muscular dystrophy","volume":"26","author":"Wang","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.molmed.2024.01.007_bb0450","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1038\/s41467-023-40555-9","article-title":"Spatial transcriptomics reveal markers of histopathological changes in Duchenne muscular dystrophy mouse models","volume":"14","author":"Heezen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.01.007_bb0455","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41419-023-06103-5","article-title":"Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations","volume":"14","author":"Su\u00e1rez-Calvet","year":"2023","journal-title":"J. Cell Death Dis."},{"key":"10.1016\/j.molmed.2024.01.007_bb0460","doi-asserted-by":"crossref","first-page":"29691","DOI":"10.1073\/pnas.2018391117","article-title":"Degenerative and regenerative pathways underlying Duchenne muscular dystrophy revealed by single-nucleus RNA sequencing","volume":"117","author":"Chemello","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.01.007_bb0465","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm1479","article-title":"Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors","volume":"12","author":"Minetti","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.01.007_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105751","article-title":"Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy","volume":"170","author":"Giovarelli","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.molmed.2024.01.007_bb0475","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13395-021-00273-6","article-title":"The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene","volume":"11","author":"Licandro","year":"2021","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.molmed.2024.01.007_bb0480","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13395-020-00251-4","article-title":"A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy","volume":"10","author":"Farr","year":"2020","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.molmed.2024.01.007_bb0485","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1139\/apnm-2016-0173","article-title":"Sodium 4-phenylbutyrate reduces myofiber damage in a mouse model of Duchenne muscular dystrophy","volume":"41","author":"Begam","year":"2016","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"10.1016\/j.molmed.2024.01.007_bb0490","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1096\/fj.13-244798","article-title":"Low doses of arginine butyrate derivatives improve dystrophic phenotype and restore membrane integrity in DMD models","volume":"28","author":"Vianello","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.molmed.2024.01.007_bb0495","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/emmm.201202096","article-title":"Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old mdx mice","volume":"5","author":"Mozzetta","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.molmed.2024.01.007_bb0500","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202254721","article-title":"Determinants of epigenetic resistance to HDAC inhibitors in dystrophic fibro-adipogenic progenitors","volume":"23","author":"Consalvi","year":"2022","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molmed.2024.01.007_bb0505","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2119\/molmed.2013.00011","article-title":"Preclinical studies in the mdx mouse model of Duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat","volume":"19","author":"Consalvi","year":"2013","journal-title":"Mol. Med."},{"key":"10.1016\/j.molmed.2024.01.007_bb0510","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.nmd.2016.07.002","article-title":"Histological effects of givinostat in boys with Duchenne muscular dystrophy","volume":"26","author":"Bettica","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.molmed.2024.01.007_bb0515","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev.physiol.010908.163216","article-title":"Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies","volume":"71","author":"Wallace","year":"2009","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0520","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-genom-090314-025003","article-title":"The pathogenesis and therapy of muscular dystrophies","volume":"16","author":"Guiraud","year":"2015","journal-title":"Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.molmed.2024.01.007_bb0525","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/hmg\/ddab276","article-title":"Sarcospan increases laminin-binding capacity of \u03b1-dystroglycan to ameliorate DMD independent of Galgt2","volume":"31","author":"Mamsa","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2024.01.007_bb0530","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0960-8966(98)00093-5","article-title":"Transforming growth factor-beta 1 and fibrosis in congenital muscular dystrophies","volume":"9","author":"Bernasconi","year":"1999","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.molmed.2024.01.007_bb0535","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13395-020-00224-7","article-title":"Acute conversion of patient-derived Duchenne muscular dystrophy iPSC into myotubes reveals constitutive and inducible over-activation of TGF\u03b2-dependent pro-fibrotic signaling","volume":"10","author":"Caputo","year":"2020","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.molmed.2024.01.007_bb0540","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.celrep.2016.05.016","article-title":"Concordant but varied phenotypes among Duchenne muscular dystrophy patient-specific myoblasts derived using a human iPSC-based model","volume":"15","author":"Choi","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2024.01.007_bb0545","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1093\/hmg\/ddu390","article-title":"Excess SMAD signaling contributes to heart and muscle dysfunction in muscular dystrophy","volume":"23","author":"Goldstein","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2024.01.007_bb0550","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/nm.3990","article-title":"Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division","volume":"21","author":"Dumont","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.01.007_bb0555","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.stem.2018.03.022","article-title":"The dystrophin glycoprotein complex regulates the epigenetic activation of muscle stem cell commitment","volume":"22","author":"Chang","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0560","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.stem.2019.01.002","article-title":"EGFR-Aurka signaling rescues polarity and regeneration defects in dystrophin-deficient muscle stem cells by increasing asymmetric divisions","volume":"24","author":"Wang","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0565","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.molmed.2016.04.002","article-title":"Satellite cells in muscular dystrophy - lost in polarity","volume":"22","author":"Chang","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2024.01.007_bb0570","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF01233096","article-title":"Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy","volume":"16","author":"Webster","year":"1990","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.molmed.2024.01.007_bb0575","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2010.11.039","article-title":"Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in Mdx\/MTR mice","volume":"143","author":"Sacco","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0580","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1101\/gad.293266.116","article-title":"DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation","volume":"31","author":"Latella","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2024.01.007_bb0585","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1023","article-title":"A myogenic differentiation checkpoint activated by genotoxic stress","volume":"32","author":"Puri","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2024.01.007_bb0590","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1038\/s41467-021-23577-z","article-title":"Acetylation of PAX7 controls muscle stem cell self-renewal and differentiation potential in mice","volume":"12","author":"Sincennes","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.01.007_bb0595","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050863","article-title":"HDAC inhibitors tune MiRNAs in extracellular vesicles of dystrophic muscle-resident mesenchymal cells","volume":"21","author":"Sandon\u00e0","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molmed.2024.01.007_bb0600","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/cdd.2016.70","article-title":"Autophagy regulates satellite cell ability to regenerate normal and dystrophic muscles","volume":"23","author":"Fiacco","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2024.01.007_bb0605","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature16187","article-title":"Autophagy maintains stemness by preventing senescence","volume":"7584","author":"Garc\u00eda-Prat","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.01.007_bb0610","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.258429","article-title":"Interplay between myofibers and pro-inflammatory macrophages controls muscle damage in mdx mice","volume":"134","author":"Saclier","year":"2021","journal-title":"Cell Sci."},{"key":"10.1016\/j.molmed.2024.01.007_bb0615","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.bor.0000179948.65895.1a","article-title":"Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis","volume":"17","author":"Tidball","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0620","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nature07414","article-title":"Sarcolemma-localized nNOS is required to maintain activity after mild exercise","volume":"456","author":"Kobayashi","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.01.007_bb0625","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1242\/jcs.086629","article-title":"Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle","volume":"124","author":"Uezumi","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2024.01.007_bb0630","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/ncb2015","article-title":"Muscle injury activates resident fibro\/adipogenic progenitors that facilitate myogenesis","volume":"12","author":"Joe","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0635","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm.3869","article-title":"Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro\/adipogenic progenitors","volume":"21","author":"Lemos","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.01.007_bb0640","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1101\/gad.234468.113","article-title":"HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles","volume":"28","author":"Saccone","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2024.01.007_bb0645","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0070-2153(08)60073-3","article-title":"The cell cycle, cell lineages, and cell differentiation","volume":"7","author":"Holtzer","year":"1972","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0650","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.stem.2014.12.004","article-title":"The NAD(+)-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells","volume":"16","author":"Ryall","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0655","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1016\/j.celrep.2019.05.092","article-title":"Glucose metabolism drives histone acetylation landscape transitions that dictate muscle stem cell function","volume":"27","author":"Yucel","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2024.01.007_bb0660","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd9371","article-title":"Prdm16-mediated H3K9 methylation controls fibro-adipogenic progenitors identity during skeletal muscle repair","volume":"7","author":"Biferali","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molmed.2024.01.007_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119482","article-title":"In vitro assessment of anti-fibrotic drug activity does not predict in vivo efficacy in murine models of Duchenne muscular dystrophy","volume":"279","author":"Theret","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.molmed.2024.01.007_bb0670","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1038\/s41598-020-62194-6","article-title":"Janus effect of glucocorticoids on differentiation of muscle fibro\/adipogenic progenitors","volume":"10","author":"Cerquone","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2024.01.007_bb0675","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/emboj.2010.136","article-title":"Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis","volume":"29","author":"Wilting","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2024.01.007_bb0680","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/s41467-017-01690-2","article-title":"Critical role of the HDAC6-cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defect","volume":"8","author":"Messaoudi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.01.007_bb0685","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cmdc.201500486","article-title":"Why hydroxamates may not be the best histone deacetylase inhibitors--what some may have forgotten or would rather forget?","volume":"11","author":"Shen","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.molmed.2024.01.007_bb0690","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40264-018-0773-9","article-title":"Safety and tolerability of histone deacetylase (HDAC) inhibitors in oncology","volume":"42","author":"Shah","year":"2019","journal-title":"Drug Saf."},{"key":"10.1016\/j.molmed.2024.01.007_bb0695","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2016.10.024","article-title":"Insulated neighborhoods: structural and functional units of mammalian gene control","volume":"167","author":"Hnisz","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0700","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cell.2017.02.007","article-title":"A phase separation model for transcriptional control","volume":"169","author":"Hnisz","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.01.007_bb0705","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1101\/gad.349160.121","article-title":"The transcription factor activity gradient (TAG) model: contemplating a contact-independent mechanism for enhancer-promoter communication","volume":"36","author":"Karr","year":"2022","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2024.01.007_bb0710","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tig.2015.11.001","article-title":"H3K9me3-dependent heterochromatin: barrier to cell fate changes","volume":"32","author":"Becker","year":"2016","journal-title":"Trends Genet."},{"key":"10.1016\/j.molmed.2024.01.007_bb0715","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/35055010","article-title":"Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases","volume":"3","author":"Taddei","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0720","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/annonc\/mdn031","article-title":"Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma","volume":"19","author":"Crump","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0725","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1158\/1078-0432.CCR-15-0530","article-title":"Panobinostat for the treatment of multiple myeloma","volume":"21","author":"Laubach","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2024.01.007_bb0730","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/2040620715592567","article-title":"Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review","volume":"6","author":"Sawas","year":"2015","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.molmed.2024.01.007_bb0735","first-page":"37","article-title":"Romidepsin in the treatment of cutaneous T-cell lymphoma","volume":"2","author":"Jain","year":"2011","journal-title":"J. Blood Med."}],"updated-by":[{"DOI":"10.1016\/j.molmed.2024.03.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000}}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T09:06:59Z","timestamp":1711789619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491424000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":147,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1471491424000078"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2024.01.007","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2024.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}